Dr. Baumann Kreuziger is Senior Medical Director of Hematology at Versiti and an Investigator at the Versiti Blood Research Institute, where she specializes in non-malignant hematology with emphasis on bleeding and clotting disorders. As founder and leader of VENUS, a network of 128+ investigators across 38+ states, she is transforming care for the 900,000 Americans diagnosed with venous thromboembolism (VTE) each year.
Her research focuses on critical gaps in women's health, including:
- Anticoagulation in pregnancy: Leading multi-center studies determining the safest management of blood thinners around delivery
- Thrombosis in pregnancy: Co-founding VENUS with a dedicated Women & Thrombosis committee
- Iron deficiency: Revealing that only 9% of women on blood thinners are screened for this critical condition
- Patient-centered care: Studying how pregnant patients weigh treatment decisions that balance bleeding risk, clotting risk, and breastfeeding goals
Dr. Baumann Kreuziger is a Professor in the Department of Medicine at the Medical College of Wisconsin and serves as co-lead of the NHLBI REDS-IV-P Wisconsin hub examining blood transfusion during pregnancy and postpartum.